The board of Tissue Regenix Group plc announced that Antony Odell, Chief Executive Officer (CEO), will be stepping down from his role and position on the Board with immediate effect. The Board will commence a process for appointment of a new CEO. In the interim, John Samuel, Non- Executive Chairman has assumed the role of Executive Chairman.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62 GBX | +0.81% | +0.81% | +19.23% |
Mar. 19 | Tissue Regenix annual loss narrows sharply as revenue jumps | AN |
Mar. 19 | Earnings Flash (TRX.L) TISSUE REGENIX GROUP Reports FY23 Revenue $29.5M | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.23% | 54.36M | |
+5.11% | 32.95B | |
+18.09% | 7.82B | |
+32.81% | 4.17B | |
-26.40% | 2.72B | |
-32.48% | 1.15B | |
+11.58% | 980M | |
-36.79% | 873M | |
-24.69% | 831M | |
-15.67% | 688M |
- Stock Market
- Equities
- TRX Stock
- News Tissue Regenix Group plc
- Tissue Regenix Group plc Announces Executive Changes